Nuveen’s ClearPoint Neuro CLPT Stock Holding History

Nuveen’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	72,990 +10,488	+17%	+$131K	﹤0.01%	2804
2026 Q1	$569K	Buy	62,502 +483	+0.8%	+$6.1K	﹤0.01%	2788
2025 Q4	$848K	Hold	62,019	–	–	﹤0.01%	2688
2025 Q3	$1.35M	Hold	62,019	–	–	﹤0.01%	2476
2025 Q2	$741K	Buy	+62,019	New	+$780K	﹤0.01%	2736
2024 Q2	–	Sell	-33,564	Closed	-$228K	–	3349
2024 Q1	$228K	Buy	33,564 +1,769	+6%	+$12.4K	﹤0.01%	3158
2023 Q4	$216K	Hold	31,795	–	–	﹤0.01%	3206
2023 Q3	$159K	Hold	31,795	–	–	﹤0.01%	3075
2023 Q2	$230K	Buy	+31,795	New	+$270K	﹤0.01%	3061
2022 Q2	–	Sell	-44,545	Closed	-$416K	–	3284
2022 Q1	$416K	Hold	44,545	–	–	﹤0.01%	3066
2021 Q4	$480K	Hold	44,545	–	–	﹤0.01%	3081
2021 Q3	$874K	Hold	44,545	–	–	﹤0.01%	3034
2021 Q2	$850K	Buy	+44,545	New	+$861K	﹤0.01%	3063

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

Nuveen's CLPT Position: Q2 2026 in Review

Nuveen increased its ClearPoint Neuro (CLPT) stake by 17% in Q2 2026, buying an estimated $131K and bringing the position to 72,990 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2804.

Nuveen first reported a position in CLPT in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.35M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

Nuveen held 72,990 shares of ClearPoint Neuro worth $1.3M as of Q2 2026.
Nuveen bought 10,488 ClearPoint Neuro shares in Q2 2026, an estimated $131K.
ClearPoint Neuro made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2804 holding.
Nuveen first reported a position in ClearPoint Neuro in Q2 2021 and has held it in 13 quarters since.
Nuveen's ClearPoint Neuro position peaked at $1.35M in Q3 2025.
129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.